vs
Healthpeak Properties（DOC）与Fortrea Holdings Inc.（FTRE）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是Fortrea Holdings Inc.的1.1倍（$719.4M vs $660.5M），Healthpeak Properties净利率更高（73.2% vs -4.9%，领先78.1%），Healthpeak Properties同比增速更快（3.1% vs -5.2%），Healthpeak Properties自由现金流更多（$357.0M vs $121.6M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs -0.1%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
Fortrea Holdings Inc.是一家总部位于美国北卡罗来纳州达勒姆、注册地为特拉华州的合同研究组织，业务覆盖90个国家，主要服务制药、生物技术和医疗器械行业客户，为相关领域的研发提供专业支持。
DOC vs FTRE — 直观对比
营收规模更大
DOC
是对方的1.1倍
$660.5M
营收增速更快
DOC
高出8.3%
-5.2%
净利率更高
DOC
高出78.1%
-4.9%
自由现金流更多
DOC
多$235.4M
$121.6M
两年增速更快
DOC
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $660.5M |
| 净利润 | $114.0M | $-32.5M |
| 毛利率 | — | — |
| 营业利润率 | 17.4% | -2.1% |
| 净利率 | 73.2% | -4.9% |
| 营收同比 | 3.1% | -5.2% |
| 净利润同比 | 2406.4% | 46.9% |
| 每股收益（稀释后） | $0.16 | $-0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCFTRE
| Q4 25 | $719.4M | $660.5M | ||
| Q3 25 | $705.9M | $701.3M | ||
| Q2 25 | $694.3M | $710.3M | ||
| Q1 25 | $702.9M | $651.3M | ||
| Q4 24 | $698.0M | $697.0M | ||
| Q3 24 | $700.4M | $674.9M | ||
| Q2 24 | $695.5M | $662.4M | ||
| Q1 24 | $606.6M | $662.1M |
净利润DOCFTRE
| Q4 25 | $114.0M | $-32.5M | ||
| Q3 25 | $-117.1M | $-15.9M | ||
| Q2 25 | $31.7M | $-374.9M | ||
| Q1 25 | $42.8M | $-562.9M | ||
| Q4 24 | $4.5M | $-61.2M | ||
| Q3 24 | $85.9M | $-27.9M | ||
| Q2 24 | $146.0M | $-138.4M | ||
| Q1 24 | $6.7M | $-101.0M |
毛利率DOCFTRE
| Q4 25 | — | — | ||
| Q3 25 | 58.6% | — | ||
| Q2 25 | 60.2% | — | ||
| Q1 25 | 61.1% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 60.0% | — | ||
| Q2 24 | 60.6% | — | ||
| Q1 24 | 59.8% | — |
营业利润率DOCFTRE
| Q4 25 | 17.4% | -2.1% | ||
| Q3 25 | 9.2% | -1.2% | ||
| Q2 25 | 5.7% | -46.5% | ||
| Q1 25 | 7.7% | -79.9% | ||
| Q4 24 | -2.2% | -8.0% | ||
| Q3 24 | 14.1% | -2.7% | ||
| Q2 24 | 22.3% | -7.7% | ||
| Q1 24 | 3.7% | -5.6% |
净利率DOCFTRE
| Q4 25 | 73.2% | -4.9% | ||
| Q3 25 | -16.6% | -2.3% | ||
| Q2 25 | 4.6% | -52.8% | ||
| Q1 25 | 6.1% | -86.4% | ||
| Q4 24 | 0.7% | -8.8% | ||
| Q3 24 | 12.3% | -4.1% | ||
| Q2 24 | 21.0% | -20.9% | ||
| Q1 24 | 1.1% | -15.3% |
每股收益（稀释后）DOCFTRE
| Q4 25 | $0.16 | $-0.25 | ||
| Q3 25 | $-0.17 | $-0.17 | ||
| Q2 25 | $0.05 | $-4.14 | ||
| Q1 25 | $0.06 | $-6.25 | ||
| Q4 24 | $0.02 | $-0.68 | ||
| Q3 24 | $0.12 | $-0.31 | ||
| Q2 24 | $0.21 | $-1.55 | ||
| Q1 24 | $0.01 | $-1.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $174.6M |
| 总债务越低越好 | $9.8B | — |
| 股东权益账面价值 | $7.5B | $563.5M |
| 总资产 | $20.3B | $2.7B |
| 负债/权益比越低杠杆越低 | 1.31× | — |
8季度趋势，按日历期对齐
现金及短期投资DOCFTRE
| Q4 25 | $467.5M | $174.6M | ||
| Q3 25 | $91.0M | $131.3M | ||
| Q2 25 | $89.4M | $81.2M | ||
| Q1 25 | $70.6M | $101.6M | ||
| Q4 24 | $119.8M | $118.5M | ||
| Q3 24 | $180.4M | $105.3M | ||
| Q2 24 | $106.9M | $126.2M | ||
| Q1 24 | $101.8M | $92.8M |
总债务DOCFTRE
| Q4 25 | $9.8B | — | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | — | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — | ||
| Q1 24 | $8.8B | — |
股东权益DOCFTRE
| Q4 25 | $7.5B | $563.5M | ||
| Q3 25 | $7.6B | $580.8M | ||
| Q2 25 | $7.9B | $589.2M | ||
| Q1 25 | $8.2B | $858.8M | ||
| Q4 24 | $8.4B | $1.4B | ||
| Q3 24 | $8.6B | $1.5B | ||
| Q2 24 | $8.8B | $1.5B | ||
| Q1 24 | $8.9B | $1.6B |
总资产DOCFTRE
| Q4 25 | $20.3B | $2.7B | ||
| Q3 25 | $19.6B | $2.7B | ||
| Q2 25 | $19.8B | $2.8B | ||
| Q1 25 | $19.8B | $3.1B | ||
| Q4 24 | $19.9B | $3.6B | ||
| Q3 24 | $20.0B | $3.7B | ||
| Q2 24 | $20.2B | $3.6B | ||
| Q1 24 | $20.5B | $4.2B |
负债/权益比DOCFTRE
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — | ||
| Q1 24 | 0.99× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $129.1M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $121.6M |
| 自由现金流率自由现金流/营收 | 49.6% | 18.4% |
| 资本支出强度资本支出/营收 | 124.4% | 1.1% |
| 现金转化率经营现金流/净利润 | 10.99× | — |
| 过去12个月自由现金流最近4个季度 | — | $88.3M |
8季度趋势，按日历期对齐
经营现金流DOCFTRE
| Q4 25 | $1.3B | $129.1M | ||
| Q3 25 | $315.0M | $86.8M | ||
| Q2 25 | $363.5M | $21.8M | ||
| Q1 25 | $279.4M | $-124.2M | ||
| Q4 24 | $1.1B | $17.1M | ||
| Q3 24 | $318.2M | $-2.4M | ||
| Q2 24 | $316.2M | $273.7M | ||
| Q1 24 | $152.6M | $-25.6M |
自由现金流DOCFTRE
| Q4 25 | $357.0M | $121.6M | ||
| Q3 25 | — | $79.5M | ||
| Q2 25 | — | $14.3M | ||
| Q1 25 | — | $-127.1M | ||
| Q4 24 | $333.7M | $13.9M | ||
| Q3 24 | — | $-10.6M | ||
| Q2 24 | — | $262.5M | ||
| Q1 24 | — | $-34.9M |
自由现金流率DOCFTRE
| Q4 25 | 49.6% | 18.4% | ||
| Q3 25 | — | 11.3% | ||
| Q2 25 | — | 2.0% | ||
| Q1 25 | — | -19.5% | ||
| Q4 24 | 47.8% | 2.0% | ||
| Q3 24 | — | -1.6% | ||
| Q2 24 | — | 39.6% | ||
| Q1 24 | — | -5.3% |
资本支出强度DOCFTRE
| Q4 25 | 124.4% | 1.1% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | 105.6% | 0.5% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | — | 1.4% |
现金转化率DOCFTRE
| Q4 25 | 10.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.48× | — | ||
| Q1 25 | 6.52× | — | ||
| Q4 24 | 235.43× | — | ||
| Q3 24 | 3.71× | — | ||
| Q2 24 | 2.17× | — | ||
| Q1 24 | 22.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
